{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:40:02Z","timestamp":1792003202563,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12149-025-02098-5","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:39:58Z","timestamp":1755013198000},"page":"1347-1358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Are [18F]FDG PET\/CT imaging and cell blood count-derived biomarkers robust non-invasive surrogates for tumor-infiltrating lymphocytes in early-stage breast cancer?"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2584-5478","authenticated-orcid":false,"given":"Romain-David","family":"Seban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Rebaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lounes","family":"Djerroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vincent-Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois-Clement","family":"Bidard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Buvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"2098_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0165-6","volume":"4","author":"SE Stanton","year":"2016","unstructured":"Stanton SE, Disis ML. Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J Immunother Cancer. 2016;4: 59.","journal-title":"J Immunother Cancer"},{"key":"2098_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.breast.2017.03.010","volume":"37","author":"G Pruneri","year":"2018","unstructured":"Pruneri G, Vingiani A, Denkert C. Tumor infiltrating lymphocytes in early breast cancer. Breast. 2018;37:207\u201314.","journal-title":"Breast"},{"key":"2098_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert C, von Minckwitz G, Darb-Esfahani S, Lederer B, Heppner BI, Weber KE, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19:40\u201350.","journal-title":"Lancet Oncol"},{"key":"2098_CR4","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1038\/s41379-020-0561-9","volume":"33","author":"J-C Tille","year":"2020","unstructured":"Tille J-C, Vieira AF, Saint-Martin C, Djerroudi L, Furhmann L, Bidard F-C, et al. Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma. Mod Pathol. 2020;33:2198\u2013207.","journal-title":"Mod Pathol"},{"key":"2098_CR5","doi-asserted-by":"publisher","first-page":"TPS629","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS629","volume":"42","author":"SR Stecklein","year":"2024","unstructured":"Stecklein SR, Aripoli A, Salgado R, O\u2019Dea A, Nye LE, Larson KE, et al. NeoTRACT: Phase II trial of neoadjuvant tumor infiltrating lymphocyte- and response-adapted chemoimmunotherapy for triple-negative breast cancer (TNBC). JCO. 2024;42:TPS629\u2013TPS629.","journal-title":"JCO"},{"key":"2098_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.21873\/anticanres.16141","volume":"43","author":"Y Kimura","year":"2023","unstructured":"Kimura Y, Sasada S, Emi A, Masumoto N, Kadoya T, Arihiro K, et al. 18F-fluorodeoxyglucose positron emission tomography\/computed tomography predicts tumor immune microenvironment function in early triple-negative breast cancer. Anticancer Res. 2023;43:127\u201336.","journal-title":"Anticancer Res"},{"key":"2098_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12032-023-02036-3","volume":"40","author":"K Frankowska","year":"2023","unstructured":"Frankowska K, Zarobkiewicz M, D\u0105browska I, Bojarska-Junak A. Tumor infiltrating lymphocytes and radiological picture of the tumor. Med Oncol. 2023;40:176.","journal-title":"Med Oncol"},{"key":"2098_CR8","doi-asserted-by":"publisher","first-page":"12046","DOI":"10.1038\/s41598-021-91404-y","volume":"11","author":"S Park","year":"2021","unstructured":"Park S, Min E-K, Bae SJ, Cha C, Kim D, Lee J, et al. Relationship of the standard uptake value of 18F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring \u2265 1 cm. Sci Rep. 2021;11:12046.","journal-title":"Sci Rep"},{"key":"2098_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10549-020-05619-0","volume":"181","author":"T Hirakata","year":"2020","unstructured":"Hirakata T, Fujii T, Kurozumi S, Katayama A, Honda C, Yanai K, et al. FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer. Breast Cancer Res Treat. 2020;181:331\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"2098_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.108773","volume":"123","author":"W Murakami","year":"2020","unstructured":"Murakami W, Tozaki M, Sasaki M, Hida AI, Ohi Y, Kubota K, et al. Correlation between 18F-FDG uptake on PET\/MRI and the level of tumor-infiltrating lymphocytes (TILs) in triple-negative and HER2-positive breast cancer. Eur J Radiol. 2020;123: 108773.","journal-title":"Eur J Radiol"},{"key":"2098_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10549-019-05339-0","volume":"177","author":"S Sasada","year":"2019","unstructured":"Sasada S, Shiroma N, Goda N, Kajitani K, Emi A, Masumoto N, et al. The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer. Breast Cancer Res Treat. 2019;177:651\u20137.","journal-title":"Breast Cancer Res Treat"},{"key":"2098_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05322-2","author":"R-D Seban","year":"2021","unstructured":"Seban R-D, Rouzier R, Latouche A, Deleval N, Guinebretiere J-M, Buvat I, et al. Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET\/CT as independent prognostic biomarkers of recurrence in resected breast cancer. Eur J Nucl Med Mol Imaging. 2021. https:\/\/doi.org\/10.1007\/s00259-021-05322-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2098_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01563-7","volume":"24","author":"H Onagi","year":"2022","unstructured":"Onagi H, Horimoto Y, Sakaguchi A, Ikarashi D, Yanagisawa N, Nakayama T, et al. High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs. Breast Cancer Res. 2022;24: 67.","journal-title":"Breast Cancer Res"},{"key":"2098_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/his.15125","author":"JJX Li","year":"2024","unstructured":"Li JJX, Ni SYB, Tsang JYS, Chan WY, Hung RKW, Lui JWH, et al. Neutrophil-lymphocyte ratio reflects tumour-infiltrating lymphocytes and tumour-associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy. Histopathology. 2024. https:\/\/doi.org\/10.1111\/his.15125.","journal-title":"Histopathology"},{"key":"2098_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2214\/AJR.20.25223","volume":"217","author":"DC Teichgraeber","year":"2021","unstructured":"Teichgraeber DC, Guirguis MS, Whitman GJ. Breast cancer staging: updates in the AJCC cancer staging manual, 8th edition, and current challenges for radiologists, from the AJR special series on cancer staging. AJR Am J Roentgenol. 2021;217:278\u201390.","journal-title":"AJR Am J Roentgenol"},{"key":"2098_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn H-J. Strategies for subtypes\u2013dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736\u201347.","journal-title":"Ann Oncol"},{"key":"2098_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41523-021-00346-1","volume":"7","author":"K El Bairi","year":"2021","unstructured":"El Bairi K, Haynes HR, Blackley E, Fineberg S, Shear J, Turner S, et al. The tale of TILs in breast cancer: a report from the International immuno-oncology biomarker working group. NPJ Breast Cancer. 2021;7:150.","journal-title":"NPJ Breast Cancer"},{"key":"2098_CR18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2098_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13550-020-00660-y","volume":"10","author":"JW Lee","year":"2020","unstructured":"Lee JW, Kim SY, Han SW, Lee JE, Lee HJ, Heo NH, et al. [18F]FDG uptake of bone marrow on PET\/CT for predicting distant recurrence in breast cancer patients after surgical resection. EJNMMI Res. 2020;10:72.","journal-title":"EJNMMI Res"},{"key":"2098_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200936","volume":"13","author":"U Cho","year":"2018","unstructured":"Cho U, Park HS, Im SY, Yoo CY, Jung JH, Suh YJ, et al. Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer. PLoS ONE. 2018;13: e0200936.","journal-title":"PLoS ONE"},{"key":"2098_CR21","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1186\/s12885-020-07700-9","volume":"20","author":"J-Y Kim","year":"2020","unstructured":"Kim J-Y, Jung EJ, Kim J-M, Lee HS, Kwag S-J, Park J-H, et al. Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis. BMC Cancer. 2020;20:1206.","journal-title":"BMC Cancer"},{"key":"2098_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","volume":"93","author":"Y Benjamini","year":"2006","unstructured":"Benjamini Y, Krieger AM, Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;93:491\u2013507.","journal-title":"Biometrika"},{"key":"2098_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/bioinformatics\/btz470","volume":"36","author":"TT Le","year":"2020","unstructured":"Le TT, Fu W, Moore JH. Scaling tree-based automated machine learning to biomedical big data with a feature set selector. Bioinformatics. 2020;36:250\u20136.","journal-title":"Bioinformatics"},{"key":"2098_CR24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, O\u2019Malley MMR, Kay J, Mueller SN, et al. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24:554\u201377.","journal-title":"Nat Rev Cancer"},{"key":"2098_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-05126-w","author":"R-D Seban","year":"2021","unstructured":"Seban R-D, Champion L, Schwartz LH, Dercle L. Spleen glucose metabolism on [18F]-FDG PET\/CT: a dynamic double-edged biomarker predicting outcome in cancer patients. Eur J Nucl Med Mol Imaging. 2021. https:\/\/doi.org\/10.1007\/s00259-020-05126-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2098_CR26","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s42255-023-00853-4","volume":"5","author":"Y Wang","year":"2023","unstructured":"Wang Y, Xu M, Sun J, Li X, Shi H, Wang X, et al. Glycolytic neutrophils accrued in the spleen compromise anti-tumour T cell immunity in breast cancer. Nat Metab. 2023;5:1408\u201322.","journal-title":"Nat Metab"},{"key":"2098_CR27","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1007\/s00259-023-06394-y","volume":"50","author":"R-D Seban","year":"2023","unstructured":"Seban R-D, Arnaud E, Loirat D, Cabel L, Cottu P, Djerroudi L, et al. [18F]FDG PET\/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab. Eur J Nucl Med Mol Imaging. 2023;50:4024\u201335.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2098_CR28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2967\/jnumed.116.177659","volume":"58","author":"AT Mayer","year":"2017","unstructured":"Mayer AT, Natarajan A, Gordon SR, Maute RL, McCracken MN, Ring AM, et al. Practical immuno-PET radiotracer design considerations for human immune checkpoint imaging. J Nucl Med. 2017;58:538\u201346.","journal-title":"J Nucl Med"},{"key":"2098_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.761163","volume":"8","author":"J Feng","year":"2021","unstructured":"Feng J, Li J, Huang X, Yi J, Wu H, Zou X, et al. Nomogram to predict tumor-infiltrating lymphocytes in breast cancer patients. Front Mol Biosci. 2021;8: 761163.","journal-title":"Front Mol Biosci"},{"key":"2098_CR30","doi-asserted-by":"publisher","first-page":"P3-03-24","DOI":"10.1158\/1538-7445.SABCS21-P3-03-24","volume":"82","author":"Y Huang","year":"2022","unstructured":"Huang Y, Lin Y. Abstract P3\u201303\u201324: Machine learning approach to predict the level of tumor-infiltrating lymphocytes of breast cancer via MRI-based radiomics. Cancer Res. 2022;82:P3-03\u201324.","journal-title":"Cancer Res"},{"key":"2098_CR31","doi-asserted-by":"publisher","DOI":"10.1055\/a-2512-8212","author":"\u00d6 Vural Topuz","year":"2025","unstructured":"Vural Topuz \u00d6, Ba\u011fbudar S, Aksu A, S\u00f6ylemez Akkurt T, Akka\u015f BE. Radiomic signatures derived from baseline 18F FDG PET\/CT imaging can predict tumor-infiltrating lymphocyte values in patients with primary breast cancer. Nuklearmedizin. 2025. https:\/\/doi.org\/10.1055\/a-2512-8212.","journal-title":"Nuklearmedizin"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02098-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02098-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02098-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T21:04:53Z","timestamp":1762808693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02098-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2098"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02098-5","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}